Chemclin Diagnostics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	118.15	105.92	400.25	448.66	342.14	311.63
Short-Term Investments	-	207.97	-	-	-	-
Trading Asset Securities	270.55	301.22	509	470	643	613
Cash & Short-Term Investments	388.7	615.11	909.25	918.66	985.14	924.63
Cash Growth	-56.19%	-32.35%	-1.02%	-6.75%	6.54%	67.08%
Accounts Receivable	9.46	14.51	20.31	25.29	34.06	35.13
Other Receivables	3.47	18.92	25.1	6.48	2.94	3.21
Receivables	12.93	33.44	45.41	31.77	37.01	38.34
Inventory	111.11	110.05	109.26	110.61	112.56	122.36
Other Current Assets	230	2.99	3.76	41.59	30.55	5.96
Total Current Assets	742.73	761.59	1,068	1,103	1,165	1,091
Property, Plant & Equipment	460.25	467.2	483.65	495.01	223.44	157.85
Long-Term Investments	-	252.61	-	-	-	-
Goodwill	153.76	153.76	153.76	153.76	153.76	153.76
Other Intangible Assets	33.96	35.44	41.48	34.24	13.97	13.75
Long-Term Accounts Receivable	-	2.79	-	-	-	-
Long-Term Deferred Tax Assets	31.74	31.79	31.51	22.08	15.17	10.7
Long-Term Deferred Charges	48.38	48.73	54.08	12.84	19.59	3.55
Other Long-Term Assets	293.13	7.04	-	-	-	-
Total Assets	1,764	1,761	1,832	1,821	1,591	1,431
Accounts Payable	16.32	3.86	9.74	90.24	67.75	22.03
Accrued Expenses	9.19	13.27	19.4	22.22	38.88	24.13
Current Portion of Long-Term Debt	50.98	40.15	20.19	-	-	-
Current Portion of Leases	-	9.01	5.25	6.66	10.9	11.39
Current Income Taxes Payable	10.83	4.72	4.88	9.61	16.48	9.28
Current Unearned Revenue	13.16	13.06	9.6	6.91	4.58	3.57
Other Current Liabilities	55.09	75.48	114.29	58.5	58.67	51.16
Total Current Liabilities	155.57	159.54	183.35	194.13	197.25	121.56
Long-Term Debt	160.19	160.19	200.19	196.67	-	-
Long-Term Leases	21.44	22.62	24.12	31.28	1.57	13.22
Long-Term Unearned Revenue	2.71	2.75	-	-	-	5
Long-Term Deferred Tax Liabilities	4.19	4.95	8.18	9.68	11.77	12.46
Total Liabilities	344.1	350.05	415.85	431.76	210.59	152.23
Common Stock	401.11	401.11	401.11	401	401	401
Additional Paid-In Capital	565.66	565.66	565.66	564.92	564.92	547.48
Retained Earnings	504.18	495.22	500.63	422.88	414.65	330.2
Treasury Stock	-51.09	-51.09	-51.09	-	-	-
Shareholders' Equity	1,420	1,411	1,416	1,389	1,381	1,279
Total Liabilities & Equity	1,764	1,761	1,832	1,821	1,591	1,431
Total Debt	232.62	231.97	249.76	234.61	12.47	24.6
Net Cash (Debt)	156.08	383.14	659.5	684.05	972.67	900.03
Net Cash Growth	-75.14%	-41.90%	-3.59%	-29.67%	8.07%	62.64%
Net Cash Per Share	0.37	0.96	1.66	1.72	2.42	2.33
Filing Date Shares Outstanding	394.59	394.59	394.59	401	401	401
Total Common Shares Outstanding	394.59	394.59	394.59	401	401	401
Working Capital	587.16	602.05	884.33	908.49	968	969.74
Book Value Per Share	3.60	3.58	3.59	3.46	3.44	3.19
Tangible Book Value	1,232	1,222	1,221	1,201	1,213	1,111
Tangible Book Value Per Share	3.12	3.10	3.09	2.99	3.02	2.77
Buildings	-	306.04	306.04	-	-	-
Machinery	-	435.57	446.91	391.37	381.13	383.66
Construction In Progress	-	6.38	0.58	365.61	103.13	7.57